BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3288989)

  • 1. Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways.
    Alonso T; Morgan RO; Marvizon JC; Zarbl H; Santos E
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4271-5. PubMed ID: 3288989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes.
    Alonso T; Srivastava S; Santos E
    Mol Cell Biol; 1990 Jun; 10(6):3117-24. PubMed ID: 2160594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors, oncogenes and inositol lipids.
    Berridge MJ
    Cancer Surv; 1986; 5(2):413-30. PubMed ID: 3779662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inositol trisphosphate as a second messenger in signal transduction processes: an essay.
    Osborne NN; Tobin AB; Ghazi H
    Neurochem Res; 1988 Mar; 13(3):177-91. PubMed ID: 2838762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
    Parries G; Hoebel R; Racker E
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2648-52. PubMed ID: 2883654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes.
    Alonso T; Santos E
    Biochem Biophys Res Commun; 1990 Aug; 171(1):14-9. PubMed ID: 2393387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production.
    Wakelam MJ; Davies SA; Houslay MD; McKay I; Marshall CJ; Hall A
    Nature; 1986 Sep 11-17; 323(6084):173-6. PubMed ID: 3018591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.
    Benjamin CW; Connor JA; Tarpley WG; Gorman RR
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4345-9. PubMed ID: 3288991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by the k-ras oncogene correlates with increases in phospholipase A2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells.
    Valitutti S; Cucchi P; Colletta G; Di Filippo C; Corda D
    Cell Signal; 1991; 3(4):321-32. PubMed ID: 1657098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the pertussis and cholera toxin substrates in normal and N-ras transformed NIH3T3 fibroblasts and an assessment of their involvement in bombesin-stimulation of inositol phospholipid metabolism.
    Milligan G; Davies SA; Houslay MD; Wakelam MJ
    Oncogene; 1989 May; 4(5):659-63. PubMed ID: 2498808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of the Ca2+-mobilizing system to serum growth factors by Ha-ras and v-mos.
    Maly K; Doppler W; Oberhuber H; Meusburger H; Hofmann J; Jaggi R; Grunicke HH
    Mol Cell Biol; 1988 Oct; 8(10):4212-6. PubMed ID: 3141785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
    Matyas GR; Fishman PH
    Cell Signal; 1989; 1(4):395-404. PubMed ID: 2561989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.
    Fleischman LF; Chahwala SB; Cantley L
    Science; 1986 Jan; 231(4736):407-10. PubMed ID: 3001936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and functions of inositol phosphates.
    Hughes AR; Putney JW
    Biofactors; 1988 Jul; 1(2):117-21. PubMed ID: 3076438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways.
    del Peso L; Lucas L; Esteve P; Lacal JC
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):519-28. PubMed ID: 9065772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts.
    Huang M; Chida K; Kamata N; Nose K; Kato M; Homma Y; Takenawa T; Kuroki T
    J Biol Chem; 1988 Dec; 263(34):17975-80. PubMed ID: 3056934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction in EJ-H-ras-transformed cells: de novo synthesis of diacylglycerol and subversion of agonist-stimulated inositol lipid metabolism.
    Chiarugi VP; Magnelli L; Pasquali F; Basi G; Ruggiero M
    FEBS Lett; 1989 Jul; 252(1-2):129-34. PubMed ID: 2668028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol trisphosphate, a novel second messenger in cellular signal transduction.
    Berridge MJ; Irvine RF
    Nature; 1984 Nov 22-28; 312(5992):315-21. PubMed ID: 6095092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
    Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
    J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of PtdIns45P2 pools under limiting inositol conditions, as assessed by liquid chromatography-tandem mass spectrometry and PtdIns45P2 mass evaluation in Ras-transformed cells.
    Berrie CP; Dragani LK; van der Kaay J; Iurisci C; Brancaccio A; Rotilio D; Corda D
    Eur J Cancer; 2002 Dec; 38(18):2463-75. PubMed ID: 12460792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.